Hi, what are you looking for?
– Pfizer will pay $295 million for the growth hormone treatment and up to $275 million in milestone payments, and royalties. Pfizer Inc. (NYSE:...
– Valeant Pharmaceuticals International Inc is abandoning its growth-by-acquisitions strategy for the time being to try to reduce debt, boost its stock price and...
– The decision gives Teva more time to transfer patients to its better patent protected double dosage Copaxone. – Teva Pharmaceutical Industries Ltd. (NYSE:...
On Monday, NewLink Genetics announced it has made a deal with drug maker Merck, to research, develop, manufacture and distribute an experimental Ebola vaccine,...
– Discount Investment and IDB Development are sharply down in an otherwise stable market. – Following the cancellation by Adama Holding Ltd. (TASE:ADMA.B1) of...
In the 23rd Nov 2014 edition of Israel’s good news, the highlights include: · With an Israeli artificial pancreas, Type 1 diabetics can stop taking insulin. · Israel has...
Israeli drug companies, such as Teva, are pretty good at producing imitation drugs quickly. Teva was truly disruptive to big pharma companies, since they...
– Dual-listed stocks under particular pressure are Opko, Teva, Israel Chemicals, Nice Systems, and Perrigo. – The Tel Aviv Stock Exchange returned from the...
Lockheed Martin Israel Ltd. and Yissum Research Development Company Ltd., the technology transfer company of the Hebrew University of Jerusalem, announced today that...
While the conflict in the Middle East, including the military operations between Israel and Gaza, and ongoing problems in Iraq and Syria, provided obstacles...